The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis

By Watson Douglas J.   Yu Qinfen   Bolognese James A.   Reicin Alise S.   Simon Thomas J.  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1539-1548

Informa Healthcare

Access to resources Recommend Favorite

Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs

By Mallen Sharon R.   Essex Margaret N.   Zhang Richard  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1359-1366

Informa Healthcare

Access to resources Recommend Favorite

Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib

By Curtis Sean P.   Ko Amy T.   Bolognese James A.   Cavanaugh Paul F.   Reicin Alise S.  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2365-2374

Informa Healthcare

Access to resources Recommend Favorite

Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs

By Watson D.J.   Bolognese J.A.   Yu C.   Krupa D.   Curtis S.  

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 1899-1908

Informa Healthcare

Access to resources Recommend Favorite

Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK

By Jansen Jeroen P.   Pellissier James   Choy Ernest H.   Ostor Andrew   Nash Julian T.   Bacon Paul   Hunsche Elke  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3069-3078

Informa Healthcare

Access to resources Recommend Favorite